About

Company description

Johnson Matthey is a leader in sustainable technologies, we apply our cutting edge science, creating solutions with our customers that make a real difference to the world around us.
We work globally with our pharmaceutical customers to deliver complex chemistry solutions for a healthier world. We produce sophisticated APIs for life-changing drugs; our expertise in controlled substances helps combat chronic pain and we employ decades of catalysis know-how to enable faster, cleaner, more efficient reactions. Our custom pharma solutions offering and worldwide manufacturing capabilities help to get your drugs to market faster, making a real difference to the quality of life.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Manufacturer
Affiliated categories: API Contract Manufacturing |Biocatalysts |Chiral Intermediates More

Upcoming events

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 40B30 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 7C20 See our Exhibitor Profile   See full Exhibitor List
24 oct 2017

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 111C10 See our Exhibitor Profile   See full Exhibitor List

News about Johnson Matthey

Johnson Matthey to offer a new process to synthesise ultra-pure cannabidiol (CBD)

28 Sep 2018

Johnson Matthey to offer a new process to synthesise ultra-pure cannabidiol (CBD)

Johnson Matthey (LSE: JMAT), a global leader in science that enables a cleaner and healthier world today announced an expansion to its API and controlled substances portfolio by establishing a new synthetic method for ultra-pure cannabidiol, a medicinal component of the cannabis plant. This synthesis will help Johnson Matthey (JM) support companies in developing novel treatments and medicines to help patients across a range of disease areas.

Read more

19 Jun 2018

Johnson Matthey wins Company of the Year 2018 at UK Chemical Industries Association Awards

Johnson Matthey, a leader in science that makes the world cleaner and healthier, has scooped the prestigious Company of the Year Award at last night’s Chemical Industries Association Awards 2018.

Read more

6 Apr 2018

Johnson Matthey Signs Exclusive Distribution Agreement with DKSH

Johnson Matthey have signed an exclusive distribution agreement with DKSH to distribute their range of high-technology catalysts in Japan.

Read more

5 Mar 2018

Johnson Matthey to offer Gusev Ester Hydrogenation Catalysts

The Gusev catalyst offers a highly reactive and selective route to produce primary alcohols from esters, an essential industrial transformation.

Read more
Johnson Matthey

Contact information

Address

Telephone

Website

View all contact information